![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 11, 8771-8774, March 15, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
,
¶
From the Departments of
Biochemistry and
§ Microbiology, University of Nevada, Reno, Nevada
89557
Received for publication, November 16, 2001, and in revised form, January 10, 2002
| |
ABSTRACT |
|---|
|
|
|---|
Caveolin-1 is a substrate for nonreceptor
tyrosine kinases including Src, Fyn, and Abl. To investigate the
function of caveolin-1 phosphorylation, we modified the Gal4-based
yeast two-hybrid system to screen for
phosphorylation-dependent protein interactions. A
cDNA library was screened using the N terminus of caveolin-1 as bait in a yeast strain expressing the catalytic domain of Abl. We
identified two proteins in this screen that interact with caveolin-1 in
a phosphorylation-dependent manner: tumor necrosis
factor- Caveolae are small, abundant plasma membrane invaginations that
have been implicated in a number of cellular processes (1). Caveolae
are formed at lipid rafts in membranes by their coat proteins, the
caveolins (2, 3). Caveolin-1 gene-deficient mice show loss of caveolae,
uncontrolled endothelial cell proliferation, and impaired nitric oxide
and calcium signaling, indicating that caveolae and caveolin-1 play
fundamental roles in organizing multiple signaling pathways (3).
However, their exact roles in these processes remain unclear.
Caveolin-1 acts as a scaffolding protein and binds to signaling
molecules through its 20-amino acid scaffolding domain (4). Caveolin-1
is also directly involved in signaling cascades as a substrate of both
serine and tyrosine kinases. Caveolin-1 is phosphorylated on tyrosine
14 by Src, Fyn, and Abl in response to a number of stimuli, including
insulin, angiotensin II, osmotic shock, and oxidative stress
(5-7).1 In fact, caveolin-1
is a preferred substrate for these tyrosine kinases in cells
(9-12).1 With the exception of sites within the activation
loops of kinases themselves, tyrosine phosphorylation is used to bind
to protein phosphotyrosine binding domains, particularly
SH22 domains (13). This in
turn leads to the activation of downstream signaling cascades.
Therefore, phosphorylation of caveolin on tyrosine is likely to be an
intermediate step in a signaling cascade occurring within caveolae.
Caveolin-1 phosphorylated on tyrosine 14 would serve as a docking site
for SH2 domain-containing proteins and would recruit proteins into
caveolae to activate downstream signaling cascades.
To identify proteins that bind to phosphorylated caveolin-1 in an
unbiased manner, we screened a 3T3-L1 adipocyte cDNA library for
proteins that interact with phosphorylated caveolin-1 using a novel
yeast dihybrid screen. We found that C-terminal Src kinase (Csk) bound
to phosphorylated caveolin in yeast and in mammalian tissue culture
cells. A possible role for Csk recruitment to caveolae in response to
caveolin-1 phosphorylation is discussed.
Phosphotyrosine-dependent Dihybrid Protein
Interaction Screen--
This protocol is a modification of the
standard yeast dihybrid screen. The bait protein was the first 61 amino
acids of caveolin-1 fused to the N terminus of the Gal4 DNA binding
domain (DBD) expressed in the vector pG4BD (Dr. Robert M. Brazas,
University of California, San Francisco, CA). This construct removes
the caveolin scaffolding domain and a stretch of negatively charged
amino acids that cause self-activation. The catalytic domain of the Abl
tyrosine kinase (Dr. W. Todd Miller, State University of New York at
Stony Brook, NY; Ref. 14) with a 5' nuclear localization sequence was
integrated into the Ade2 locus of the yeast chromosome using
a yeast integration vector YIpDCE1 (Dr. Robert Stearman, National
Institutes of Health, Bethesda, MD; Ref. 15). A 3T3-L1 adipocyte
cDNA library fused to the Gal4 activation domain (AD) was used to
screen for caveolin-1-binding proteins or "prey" (Alan R. Saltiel,
Life Sciences Institute, Ann Arbor, MI; Ref. 16). This library contains
~3 × 106 independent clones. Yeast were initially
selected for growth on His Immunoprecipitation--
NIH-3T3 or primary human fibroblast
(HF) cells (150-mm plate; Ref. 12) were lysed in 1 ml of HNTG buffer
(50 mM HEPES, pH 7.5, 150 mM NaCl, 1% Triton
X-100, 10% glycerol, 1 mM EDTA, 10 mM
Na4P2O7, 100 mM NaF, 1 mM Na3VO4, 10 µg/ml aprotinin, 1 mM benzamidine, and 0.1 mM phenylmethylsulfonyl
fluoride). HNTG buffer was used to preserve SH2 domain-phosphotyrosine
interactions (17). Cell lysates were incubated on ice for 1 h to
disrupt caveolae, and insoluble material was removed by centrifugation
(10 min at 13,500 rpm in a microcentrifuge). This incubation was
sufficient to solubilize >50% of the caveolin-1 in these cell lines.
To eliminate nonspecific binding of caveolin-1, the lysates were added
to 100 µl of packed beads (Sepharose CL-4B) and incubated on ice for 1 h, and the precleared beads were removed by centrifugation. This
preclearing step was essential. For immunoprecipitation, 30 µl of
protein A-Sepharose beads preloaded with or without 12 µg of
polyclonal anti-Csk antibody were added to the precleared lysates (0.5 ml) and incubated at 4 °C for 3 h. The beads were pelleted by
centrifugation. Immunoprecipitates were washed four times in HNTG
buffer, eluted in SDS sample buffer, and analyzed by SDS-PAGE and
Western blotting as described (12).
To identify proteins that bind to phosphorylated caveolin-1, we
screened a cDNA library using a novel yeast dihybrid screen. We
modified the Gal4-based yeast two-hybrid system to perform a
phosphotyrosine-dependent dihybrid protein interaction
screen (Fig. 1A). The
principle of the phosphotyrosine-dependent dihybrid screen
is to introduce a kinase (Abl) into the yeast two-hybrid system to
phosphorylate the bait protein (caveolin-1) and then screen for
phosphorylation-dependent protein interactions.
receptor-associated factor 2 (TRAF2) and C-terminal
Src kinase (Csk). TRAF2 bound to nonphosphorylated caveolin-1, but this
association was increased 3-fold by phosphorylation. In contrast,
association of Csk with caveolin-1 was completely dependent on
phosphorylation of caveolin-1, both for fusion proteins in yeast
(>35-fold difference in affinity) and for endogenous proteins in
tissue culture cells. Our data suggest that phosphorylation of
caveolin-1 leads to Csk translocation into caveolae. This may induce a
feedback loop that leads to inactivation of the Src family kinases that
are highly enriched in caveolae.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
/3-amino-1,2,4-triazole
(65 mM) plates. Of the 2 × 107
transformants screened, 134 grew well on His
plates
(colonies >2 mm). Plasmid DNAs were isolated from each one. To
identify false positives and self-activators, the plasmids were
reintroduced into the original yeast strain or cells expressing no Gal4
DBD. The isolates were sorted into 53 independent clones by PCR
amplification based on size of insert and restriction digestion pattern
(using AluI). All 53 were se- quenced.
Phosphorylation-dependent interactions were identified in
counterscreens as those interactions that were lost in yeast
strains expressing the caveolin-1 bait protein alone or expressing a
caveolin-1 bait protein with tyrosine 14 changed to phenylalanine
(caveolin-1/Y14F).
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (29K):
[in a new window]
Fig. 1.
Phosphotyrosine-dependent yeast
dihybrid protein interaction screen. A, screen:
caveolin-1 (amino acids 1-61) fused to the Gal4 DBD was used as the
"bait." The catalytic domain of Abl was expressed to phosphorylate
caveolin-1. The prey was an adipocyte cDNA library fused to the
Gal4 AD. Steps in the screen are as follows: (i) identify positive
clones by selection and screening, (ii) counterscreen for
phosphorylation-dependent interactions, and (iii) sequence
to look for SH2 domains or phosphotyrosine binding domains.
B, lysates from yeast expressing caveolin-1·Gal4 DBD, Abl,
or both were analyzed by Western blotting using antibodies to
caveolin-1 (Cav1), Gal4 DBD, Abl, and phosphocaveolin
(PY14). C, lysates from yeast expressing Abl and
caveolin-1·Gal4 DBD or caveolin-1/Y14F·Gal4 DBD (Cav1
Y14F) were analyzed.
Caveolin-1 is split into two cytoplasmic domains by a central hydrophobic membrane anchor. The only site of tyrosine phosphorylation on caveolin-1 is tyrosine 14. To mimic the native structure of caveolin-1 and prevent steric hindrance at the phosphorylation site, we expressed the N terminus of caveolin-1 as a fusion protein attached to the N terminus of the Gal4 DBD. Abl was chosen as the kinase because caveolin-1 is phosphorylated on tyrosine 14 by c-Abl in cells1 and in vitro (12). The catalytic domain of c-Abl with a 5' nuclear localization signal was integrated into the yeast chromosome. The truncated kinase was used to avoid introduction of an SH2 domain-containing protein into the system (Abl domain structure: SH3, SH2, kinase domain, and tail). The expression of the caveolin-1·Gal4 DBD fusion protein and Abl and the phosphorylation of caveolin-1 in the yeast strains were confirmed by Western blotting (Fig. 1B). In the absence of Abl or when tyrosine 14 of caveolin-1 was changed to phenylalanine (Fig. 1C), no phosphocaveolin was detected. The positive and negative controls for the standard yeast two-hybrid screen still behaved as expected after the expression of Abl kinase in the yeast cells (data not shown).
A 3T3-L1 adipocyte cDNA library fused to the Gal4 AD was
transformed into yeast expressing caveolin-1 and Abl, and transformants were selected for growth on His
/3-amino-1,2,4-triazole
plates. After elimination of false positives, self-activators, and
duplicates, we identified eight "true positive" proteins that
interact with the N terminus of caveolin-1. All but one of these were
isolated multiple times.3 Of
these eight proteins, three were known proteins, and five were unknown.
The three known proteins were JAB1 (21 isolates), tumor necrosis
factor-
receptor-associated factor 2 (TRAF2) (10 isolates), and Csk
(6 isolates). Full-length clones were isolated in all three cases, and
at least two independent clones with different inserts were isolated
for each one. Of these proteins, only Csk contains a known
phosphotyrosine binding domain, an SH2 domain.
Based on the initial screen, positive proteins could interact with
caveolin-1 in a phosphorylation-dependent or
phosphorylation-independent manner. To counterscreen for
phosphorylation-dependent interactions, all positive clones
were transformed back into yeast that expressed caveolin-1 alone,
caveolin-1 and Abl, or caveolin-1/Y14F and Abl (Fig.
2). Protein interactions were determined
by liquid culture
-galactosidase assays. The liquid culture assays
were quantitative and efficiently identified
phosphorylation-dependent interactions. Similar results
were observed when the protein interactions were determined by
selective growth or colony-lift filter
-galactosidase assays (data
not shown).
|
We found only one protein, Csk, whose interaction with caveolin-1 was completely dependent on phosphorylation (Fig. 2A). Csk activated the expression of reporter genes in cells that expressed both caveolin-1 and Abl but not in cells expressing caveolin-1 alone. The possibility that the catalytic domain of Abl acts as a bridge between Csk and caveolin-1 can be excluded because Csk did not interact with caveolin-1/Y14F despite the presence of Abl. The interaction of Csk with phosphocaveolin is moderate (23% of positive control) but significantly greater (35-45-fold) than the background levels detected with unphosphorylated caveolin-1 or caveolin-1/Y14F. To control for the specificity of the SH2 domain interaction, we also examined the interaction between full-length c-Abl and caveolin-1 in yeast cells (Fig. 2D). Full-length c-Abl did not show significant interaction with caveolin-1 or phosphocaveolin. This indicates that only specific SH2 domain-containing proteins will interact with a given tyrosine-phosphorylated bait protein in the dihybrid screen.
TRAF2 also interacted with caveolin-1 in a
phosphorylation-dependent manner (Fig. 2B).
While TRAF2 bound to nonphosphorylated caveolin-1 (50% of positive
control), phosphorylation of caveolin-1 increased the binding of TRAF2
to caveolin-1 ~3-fold. TRAF2 also bound to caveolin-1/Y14F but at a
lower affinity (25% of positive control). These data indicate that
TRAF2 binding to caveolin-1 is mediated in part through tyrosine 14. The phosphorylation dependence of the interaction is surprising as
TRAF2 does not have an identifiable phosphotyrosine binding domain. It
has been shown that TRAF2 and caveolin-1 form a constitutive complex in
mammalian cells (18). After ligand binding, the tumor necrosis
factor-
receptor redistributes in the membrane and binds to this
complex. In contrast to Csk and TRAF2, the proteasome subunit JAB1
interacted with caveolin-1 in a phosphorylation-independent manner
(Fig. 2C; ~45% of positive control in the three yeast strains).
To determine whether full-length caveolin-1 interacts with endogenous
Csk, we next examined the interaction of these proteins in tissue
culture cells (Fig. 3). The first cell
line used was an NIH-3T3 cell line expressing a temperature-sensitive
allele of v-Abl, ts-120. Caveolin-1 is
phosphorylated on tyrosine in these cells as determined by both
anti-phosphotyrosine and anti-phosphocaveolin Western
blotting4 (Ref. 12; Fig.
3A, upper panel, Lysates). Csk was
immunoprecipitated from v-Abl-expressing cells or control cells, and
immunoprecipitates were analyzed by Western blotting. Phosphocaveolin
was detected in Csk immunoprecipitates from the v-Abl-expressing cells
but not from control cells (Fig. 3A, upper panel,
IP: Csk). No phosphocaveolin was detected in mock
immunoprecipitations (Fig. 3A, upper panel, NS). When a parallel blot was probed with
anti-phosphotyrosine antibodies, we found that phosphocaveolin was one
of two major phosphoproteins that bind to Csk in the v-Abl-expressing
cells (Fig. 3A, lower panel, filled
arrows). The specificity is quite remarkable considering the
dramatic induction of total cellular tyrosine phosphorylation in
v-Abl-expressing cells (Fig. 3A, lower panel,
Lysates). The less intense 68-kDa phosphoprotein that
coimmunoprecipitated with Csk comigrates with paxillin, a multidomain
protein that localizes primarily to focal adhesions (Fig.
3A, lower panel, open arrow; data not
shown).
|
To further characterize the interaction between endogenous Csk and caveolin-1 without expression of v-Abl, we immunoprecipitated Csk from HF cells after oxidative stress.1 Caveolin-1 was phosphorylated in cells treated with H2O2, while caveolin-1 phosphorylation was undetectable in control cells (Fig. 3B, Lysates). After oxidative stress, phosphocaveolin was detected in the Csk immunoprecipitates (Fig. 3B, IP: Csk).
While phosphocaveolin was detected in the Csk immunoprecipitates, available antibodies were not sensitive enough to detect unphosphorylated caveolin-1 in these samples. To overcome this limitation, we transiently expressed full-length FLAG epitope-tagged caveolin-1 or caveolin-1/Y14F in HF cells and looked for coimmunoprecipitation of the FLAG tag with Csk before and after oxidative stress. Overexpression of epitope-tagged caveolin-1 in HF cells was sufficient to induce significant phosphorylation of caveolin-1 in the lysates (Fig. 3C, upper panel, Lysates). However, the phosphorylation was dramatically increased after oxidative stress. Caveolin-1/Y14F was not phosphorylated on any tyrosine residues even after oxidative stress,1 although phosphorylation of endogenous caveolin-1 was detected in the lysates of these cells (Fig. 3C, filled arrow).
In cells overexpressing caveolin-1, phosphocaveolin
coimmunoprecipitated with Csk both before and after induction of
oxidative stress (Fig. 3C, upper panel,
IP: Csk). No phosphocaveolin was detected in Csk
immunoprecipitates from cells expressing caveolin-1/Y14F under either
condition. Caveolin-1, as detected by the FLAG epitope tag, could only
be detected in Csk immunoprecipitates from cells expressing caveolin-1,
not caveolin-1/Y14F, despite equal expression of both constructs (Fig.
3C, lower panel). These data indicate that Csk
only binds to caveolin-1 after phosphorylation on tyrosine 14. Consistent with this, phosphocaveolin was enriched in the Csk
immunoprecipitates relative to the whole cell lysates from untreated
cells. These results support the idea that phosphorylation of caveolin
on tyrosine 14 is a mechanism to control the interaction of Csk with
caveolin-1.
| |
DISCUSSION |
|---|
|
|
|---|
What is the significance of the phosphorylation-dependent interaction of caveolin-1 and Csk? In cells, Csk negatively regulates the activities of Src family kinases by phosphorylating a conserved inhibitory tyrosine residue (527 in Src). However, the Src family kinases are localized to lipid rafts in the plasma membrane (including caveolae) via covalent lipid modifications, while Csk is not lipid modified and is largely free in the cytosol. The ability of Csk to relocate from the cytosol to the plasma membrane requires a functional SH2 domain on Csk but not the tyrosine phosphorylation sites on Src (19). Therefore, Csk must be recruited to its substrates at the plasma membrane via interaction with other tyrosine-phosphorylated proteins. Recently it has been shown in brain and cultured lymphocytes that Csk is recruited to lipid rafts in the plasma membrane through an SH2 domain interaction with a transmembrane protein called Cbp that is constitutively phosphorylated on tyrosine (20). The binding of Csk to tyrosine-phosphorylated Cbp activates Csk (21).
Our data indicate that caveolin-1 phosphorylation is another mechanism to recruit Csk to the plasma membrane. Csk binds specifically to phosphorylated caveolin-1 (Fig. 3). Caveolin-1 is one of only two phosphotyrosine proteins found to coimmunoprecipitate with Csk in the fibroblast cells used in our study (paxillin is the other). Despite the widespread distribution of Cbp, we did not detect a phosphotyrosine protein of the predicted size of Cbp in Csk immunoprecipitates from NIH-3T3 cells (Fig. 3). While caveolin-1 is expressed at very low levels in brain and lymphocytes, it is expressed at high levels in terminally differentiated cells such as endothelial cells, smooth muscle cells, and adipocytes. Therefore, caveolin-1 may be the major protein mediating Csk membrane localization in these cells.
Disruption of the Csk gene causes unregulated Src family kinase activity, increased phosphorylation of a number of substrate proteins involved in the regulation of the actin cytoskeleton, impaired stress fiber formation, and defects in cell-matrix adhesion and cell-cell adhesion (22). Interestingly a loss of caveolin-1 expression induces a number of these same effects, including increased Src kinase activity and disruption of cell-matrix adhesion (23). Several lines of evidence implicate caveolins in the regulation of the actin cytoskeleton. Disruption of caveolin-3 in mice and in humans leads to limb girdle muscular dystrophy, a disease caused by disruption of complexes between the actin cytoskeleton, the plasma membrane, and the extracellular matrix (2). Caveolin-1 at the cell surface often aligns along the underlying actin cytoskeleton, possibly through its interaction with filamin (24). In addition, phosphocaveolin is found in stabilized focal contacts in adherent cells (7), and caveolin-1 is phosphorylated in intact tissues where there are a large number of cell-cell and cell-matrix attachments (data not shown; Ref. 25).
The kinases known to phosphorylate caveolin-1, Abl, Src, and Fyn are also associated with focal adhesions. Upon integrin ligation activated Abl transiently associates with the forming focal contact (26), while Src is recruited and inactivated and remains in a stable association with these structures (27). The inactivation of Src in the focal contacts is due to phosphorylation of its inhibitory Csk site. Src activity is required for the turnover of cell-matrix contacts during cell migration and division in response to extracellular stimuli, not for focal contact formation (28, 29). Fyn is also involved in integrin signaling through a complex that requires caveolin-1 expression (8, 23).
Based on these observations we propose the following model. Activation
of Abl or Src leads to the phosphorylation of caveolin-1 on tyrosine
14. This leads to the recruitment of Csk and phosphorylation and
inactivation of Src family kinases that are highly enriched in
caveolae. Caveolin phosphorylation would induce the formation of
preassembled signaling complexes containing inactive Src family kinases
at specific sites at the cell membrane that are primed for transient
activation in response to extracellular stimuli. The caveolin-1/Csk/Src
family kinase signaling complex may be involved in transmitting signals
to the actin cytoskeleton (i.e. from integrins or oxidative
stress) or transmitting signals from the actin cytoskeleton
(i.e. from shear or osmotic stress).
| |
FOOTNOTES |
|---|
* This work was supported by National Institutes of Health Grant DK56197.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
¶ To whom correspondence should be addressed: Dept. of Biochemistry, Mail Stop 330, University of Nevada, Reno, NV 89557. Tel.: 775-784-1155; Fax: 775-784-1419; E-mail: cmastick@med.unr.edu.
Published, JBC Papers in Press, January 22, 2002, DOI 10.1074/jbc.C100661200
1 A. R. Sanguinetti and C. C. Mastick, manuscript submitted.
3 The library was screened at approximately 7-fold redundancy, therefore true positive clones are expected to be isolated multiple times.
4 Phosphocaveolin and a comigrating phosphotyrosine band coimmunoprecipitate with caveolin-1 from ts-120-expressing cells. Anti-phosphocaveolin blotting shows only bands that comigrate with caveolin-1 even in whole cell lysates.
| |
ABBREVIATIONS |
|---|
The abbreviations used are:
SH, Src homology;
caveolin-1/Y14F, caveolin-1 with tyrosine 14 mutated to phenylalanine;
Csk, C-terminal Src kinase;
Gal4 AD and Gal4 DBD, the activation and
DNA binding domains of Gal4, respectively;
HF, human fibroblast;
TRAF, tumor necrosis factor-
receptor-associated factor.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Anderson, R. G. W. (1998) Annu. Rev. Biochem. 67, 199-225[CrossRef][Medline] [Order article via Infotrieve] |
| 2. | Minetti, C., Sotgia, F., Bruno, C., Scartezzini, P., Broda, P., Bado, M., Masetti, E., Mazzocco, M., Egeo, A., Donati, M. A., Volonte, D., Galbiati, F., Cordone, G., Bricarelli, F. D., Lisanti, M. P., and Zara, F. (1998) Nat. Genet. 18, 365-368[CrossRef][Medline] [Order article via Infotrieve] |
| 3. | Drab, M., Verkade, P., Elger, M., Kasper, M., Lohn, M., Lauterbach, B., Menne, J., Lindschau, C., Mende, F., Luft, F. C., Schedl, A., Haller, H., and Kurzchalia, T. V. (2001) Science 9, 2449-2452 |
| 4. |
Okamoto, T.,
Schlegel, A.,
Scherer, P. E.,
and Lisanti, M. P.
(1998)
J. Biol. Chem.
273,
5419-5422 |
| 5. |
Mastick, C. C.,
Brady, M. J.,
and Saltiel, A. R.
(1995)
J. Cell Biol.
129,
1523-1531 |
| 6. |
Mastick, C. C.,
and Saltiel, A. R.
(1997)
J. Biol. Chem.
272,
20706-20714 |
| 7. |
Ushio-Fukai, M.,
Hilenski, L.,
Santanam, N.,
Becker, P., Ma, Y.,
Griendling, K.,
and Alexander, R.
(2001)
J. Biol. Chem.
276,
48269-48275 |
| 8. | Wary, K. K., Mariotti, A., Zurzolo, C., and Giancotti, F. G. (1998) Cell 94, 625-634[CrossRef][Medline] [Order article via Infotrieve] |
| 9. |
Glenney, J. R.
(1989)
J. Biol. Chem.
264,
20163-20166 |
| 10. | Ko, Y. G., Liu, P., Pathak, R. K., Craig, L. C., and Anderson, R. G. W. (1998) J. Cell. Biochem. 71, 524-535[CrossRef][Medline] [Order article via Infotrieve] |
| 11. |
Nomura, R.,
and Fujimoto, T.
(1999)
Mol. Biol. Cell
10,
975-986 |
| 12. | Mastick, C. C., Sanguinetti, A. R., Knesek, J. H., Mastick, G. S., and Newcomb, L. F. (2001) Exp. Cell. Res. 266, 142-154[CrossRef][Medline] [Order article via Infotrieve] |
| 13. | Zhou, S., and Cantley, L. C. (1995) Trends Biochem. Sci. 20, 470-475[CrossRef][Medline] [Order article via Infotrieve] |
| 14. |
Pellicena, P.,
Stowell, K. R.,
and Miller, W. T.
(1998)
J. Biol. Chem.
273,
15325-15328 |
| 15. | Stearman, R., Dancis, A., and Klausner, R. D. (1998) Gene (Amst.) 212, 197-202[CrossRef][Medline] [Order article via Infotrieve] |
| 16. |
Printen, J. A.,
Brady, M. J.,
and Saltiel, A. R.
(1997)
Science
275,
1475-1478 |
| 17. |
Lavan, B. E.,
Kuhne, M. R.,
Garner, C. W.,
Anderson, D.,
Reedijk, M.,
Pawson, T.,
and Lienhard, G. E.
(1992)
J. Biol. Chem.
267,
11631-11636 |
| 18. |
Feng, X.,
Gaeta, M. L.,
Madge, L. A.,
Yang, J. H.,
Bradley, J. R.,
and Pober, J. S.
(2001)
J. Biol. Chem.
276,
8341-8349 |
| 19. |
Howell, B. W.,
and Cooper, J. A.
(1994)
Mol. Cell. Biol.
14,
5402-5411 |
| 20. | Kawabuchi, M., Satomi, Y., Takao, T., Shimonishi, Y., Nada, S., Nagai, K., Tarakhovsky, A., and Okada, M. (2000) Nature 404, 999-1003[CrossRef][Medline] [Order article via Infotrieve] |
| 21. |
Takeuchi, S.,
Takayama, Y.,
Ogawa, A.,
Tamura, K.,
and Okada, M.
(2000)
J. Biol. Chem.
275,
29183-29186 |
| 22. | Thomas, S. M., Soriano, P., and Imamoto, A. (1995) Nature 376, 267-271[CrossRef][Medline] [Order article via Infotrieve] |
| 23. |
Wei, Y.,
Yang, X.,
Liu, Q.,
Wilkins, J. A.,
and Chapman, H. A.
(1999)
J. Cell Biol.
144,
1285-1294 |
| 24. | Stahlhut, M., Sandvig, K., and van Deurs, B. (2000) Exp. Cell. Res. 261, 111-118[CrossRef][Medline] [Order article via Infotrieve] |
| 25. | Aoki, T., Nomura, R., and Fujimoto, T. (1999) Exp. Cell Res. 253, 629-636[CrossRef][Medline] [Order article via Infotrieve] |
| 26. |
Lewis, J. M.,
Baskaran, R.,
Taagepera, S.,
Schwartz, M. A.,
and Wang, J. Y.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
15174-15179 |
| 27. |
Kaplan, K. B.,
Swedlow, J. R.,
Morgan, D. O.,
and Varmus, H. E.
(1995)
Genes Dev.
9,
1505-1517 |
| 28. | Fincham, V. J., and Frame, M. C. (1998) EMBO J. 17, 81-92[CrossRef][Medline] [Order article via Infotrieve] |
| 29. | Klinghoffer, R. A., Sachsenmaier, C., Cooper, J. A., and Soriano, P. (1999) EMBO J. 18, 2459-2471[CrossRef][Medline] [Order article via Infotrieve] |
This article has been cited by other articles:
![]() |
F. Peng, B. Zhang, D. Wu, A. J. Ingram, B. Gao, and J. C. Krepinsky TGF{beta}-induced RhoA activation and fibronectin production in mesangial cells require caveolae Am J Physiol Renal Physiol, July 1, 2008; 295(1): F153 - F164. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Jansen, V. M. Pietiainen, H. Polonen, L. Rasilainen, M. Koivusalo, U. Ruotsalainen, E. Jokitalo, and E. Ikonen Cholesterol Substitution Increases the Structural Heterogeneity of Caveolae J. Biol. Chem., May 23, 2008; 283(21): 14610 - 14618. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Harita, H. Kurihara, H. Kosako, T. Tezuka, T. Sekine, T. Igarashi, and S. Hattori Neph1, a Component of the Kidney Slit Diaphragm, Is Tyrosine-phosphorylated by the Src Family Tyrosine Kinase and Modulates Intracellular Signaling by Binding to Grb2 J. Biol. Chem., April 4, 2008; 283(14): 9177 - 9186. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. P. Head, H. H. Patel, Y. M. Tsutsumi, Y. Hu, T. Mejia, R. C. Mora, P. A. Insel, D. M. Roth, J. C. Drummond, and P. M. Patel Caveolin-1 expression is essential for N-methyl-D-aspartate receptor-mediated Src and extracellular signal-regulated kinase 1/2 activation and protection of primary neurons from ischemic cell death FASEB J, March 1, 2008; 22(3): 828 - 840. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. A. Torres, J. C. Tapia, D. A. Rodriguez, A. Lladser, C. Arredondo, L. Leyton, and A. F. G. Quest E-Cadherin Is Required for Caveolin-1-Mediated Down-Regulation of the Inhibitor of Apoptosis Protein Survivin via Reduced {beta}-Catenin-Tcf/Lef-Dependent Transcription Mol. Cell. Biol., November 1, 2007; 27(21): 7703 - 7717. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Khanna, S. Roy, H.-A Park, and C. K. Sen Regulation of c-Src Activity in Glutamate-induced Neurodegeneration J. Biol. Chem., August 10, 2007; 282(32): 23482 - 23490. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Grande-Garcia, A. Echarri, J. de Rooij, N. B. Alderson, C. M. Waterman-Storer, J. M. Valdivielso, and M. A. del Pozo Caveolin-1 regulates cell polarization and directional migration through Src kinase and Rho GTPases J. Cell Biol., May 21, 2007; 177(4): 683 - 694. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Peng, D. Wu, A. J. Ingram, B. Zhang, B. Gao, and J. C. Krepinsky RhoA Activation in Mesangial Cells by Mechanical Strain Depends on Caveolae and Caveolin-1 Interaction J. Am. Soc. Nephrol., January 1, 2007; 18(1): 189 - 198. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. P. Head, H. H. Patel, D. M. Roth, F. Murray, J. S. Swaney, I. R. Niesman, M. G. Farquhar, and P. A. Insel Microtubules and Actin Microfilaments Regulate Lipid Raft/Caveolae Localization of Adenylyl Cyclase Signaling Components J. Biol. Chem., September 8, 2006; 281(36): 26391 - 26399. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Orlichenko, B. Huang, E. Krueger, and M. A. McNiven Epithelial Growth Factor-induced Phosphorylation of Caveolin 1 at Tyrosine 14 Stimulates Caveolae Formation in Epithelial Cells J. Biol. Chem., February 24, 2006; 281(8): 4570 - 4579. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ushio-Fukai, L. Zuo, S. Ikeda, T. Tojo, N. A. Patrushev, and R. W. Alexander cAbl Tyrosine Kinase Mediates Reactive Oxygen Species- and Caveolin-Dependent AT1 Receptor Signaling in Vascular Smooth Muscle: Role in Vascular Hypertrophy Circ. Res., October 14, 2005; 97(8): 829 - 836. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Ratajczak, P. Oliviero, F. Marotte, F. Kolar, B. Ostadal, and J.-L. Samuel Expression and localization of caveolins during postnatal development in rat heart: implication of thyroid hormone J Appl Physiol, July 1, 2005; 99(1): 244 - 251. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ikeda, M. Ushio-Fukai, L. Zuo, T. Tojo, S. Dikalov, N. A. Patrushev, and R. W. Alexander Novel Role of ARF6 in Vascular Endothelial Growth Factor-Induced Signaling and Angiogenesis Circ. Res., March 4, 2005; 96(4): 467 - 475. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kanda, Y. Mochizuki, T. Nakamura, Y. Miyata, T. Matsuyama, and H. Kanetake Pigment epithelium-derived factor inhibits fibroblast-growth-factor-2-induced capillary morphogenesis of endothelial cells through Fyn J. Cell Sci., March 1, 2005; 118(5): 961 - 970. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Radel and V. Rizzo Integrin mechanotransduction stimulates caveolin-1 phosphorylation and recruitment of Csk to mediate actin reorganization Am J Physiol Heart Circ Physiol, February 1, 2005; 288(2): H936 - H945. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Labrecque, C. Nyalendo, S. Langlois, Y. Durocher, C. Roghi, G. Murphy, D. Gingras, and R. Beliveau Src-mediated Tyrosine Phosphorylation of Caveolin-1 Induces Its Association with Membrane Type 1 Matrix Metalloproteinase J. Biol. Chem., December 10, 2004; 279(50): 52132 - 52140. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. N. Shajahan, C. Tiruppathi, A. V. Smrcka, A. B. Malik, and R. D. Minshall G{beta}{gamma} Activation of Src Induces Caveolae-mediated Endocytosis in Endothelial Cells J. Biol. Chem., November 12, 2004; 279(46): 48055 - 48062. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Podar, R. Shringarpure, Y.-T. Tai, M. Simoncini, M. Sattler, K. Ishitsuka, P. G. Richardson, T. Hideshima, D. Chauhan, and K. C. Anderson Caveolin-1 Is Required for Vascular Endothelial Growth Factor-Triggered Multiple Myeloma Cell Migration and Is Targeted by Bortezomib Cancer Res., October 15, 2004; 64(20): 7500 - 7506. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A Cho, S. J. Ryu, Y. S. Oh, J. H. Park, J. W. Lee, H.-P. Kim, K. T. Kim, I. S. Jang, and S. C. Park Morphological Adjustment of Senescent Cells by Modulating Caveolin-1 Status J. Biol. Chem., October 1, 2004; 279(40): 42270 - 42278. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kogo, T. Aiba, and T. Fujimoto Cell Type-specific Occurrence of Caveolin-1{alpha} and -1{beta} in the Lung Caused by Expression of Distinct mRNAs J. Biol. Chem., June 11, 2004; 279(24): 25574 - 25581. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Duxbury, H. Ito, S. W. Ashley, and E. E. Whang CEACAM6 Cross-linking Induces Caveolin-1-dependent, Src-mediated Focal Adhesion Kinase Phosphorylation in BxPC3 Pancreatic Adenocarcinoma Cells J. Biol. Chem., May 28, 2004; 279(22): 23176 - 23182. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Wang, M. Haas, M. Liang, T. Cai, J. Tian, S. Li, and Z. Xie Ouabain Assembles Signaling Cascades through the Caveolar Na+/K+-ATPase J. Biol. Chem., April 23, 2004; 279(17): 17250 - 17259. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-Q. Wang, P. Sun, and A. S. Paller Ganglioside GM3 Blocks the Activation of Epidermal Growth Factor Receptor Induced by Integrin at Specific Tyrosine Sites J. Biol. Chem., December 5, 2003; 278(49): 48770 - 48778. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Nichols Caveosomes and endocytosis of lipid rafts J. Cell Sci., December 1, 2003; 116(23): 4707 - 4714. [Abstract] [Full Text] [PDF] |
||||
|
|